Litcius/Paper detail

Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry

Wilson Lin, Eduardo Aluicio‐Sarduy, Hailey Houson, Todd E. Barnhart, Volkan Tekin, Justin J. Jeffery, Ashley M. Weichmann, Kendall E. Barrett, Suzanne E. Lapi, Jonathan W. Engle

2023Nuclear Medicine and Biology14 citationsDOIOpen Access PDF

Topics & Concepts

In vivoPharmacokineticsNeurotensinDosimetryRadioimmunotherapyCytotoxicityChemistryNuclear medicineEffective dose (radiation)PharmacologyReceptorMedicineIn vitroCancer researchBiologyBiochemistryImmunologyNeuropeptideMonoclonal antibodyAntibodyBiotechnologyRadiopharmaceutical Chemistry and ApplicationsNeuroendocrine Tumor Research AdvancesNeuropeptides and Animal Physiology
Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry | Litcius